Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hennenberg

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
British Journal of Pharmacology|March 26, 2018
Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3Qingfeng Yu, Christian Gratzke, Yiming Wang, et al.
European Journal of Pharmacology|February 5, 2020
Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α<sub>1</sub>-blockersXiaolong Wang, Bingsheng Li, Anna Ciotkowska, et al.
British Journal of Pharmacology|September 18, 2016
Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2Yiming Wang, Christian Gratzke, Alexander Tamalunas, et al.
Frontiers in Pharmacology|May 15, 2023
Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003Yuhan Liu, Ruixiao Wang, Ru Huang, et al.
Journal of Hepatology|July 17, 2010
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cellsJonel Trebicka, Martin Hennenberg, Margarete Odenthal, et al.
Frontiers in Pharmacology|April 23, 2020
Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766Bingsheng Li, Qingfeng Yu, Ruixiao Wang, et al.
The Prostate|February 28, 2019
New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic interventionQingfeng Yu, Christian Gratzke, Yiming Wang, et al.
European Journal of Pharmacology|March 19, 2017
Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow regionMartin Hennenberg, Alexander Tamalunas, Yiming Wang, et al.
The Prostate|May 26, 2020
Inhibition of neurogenic and thromboxane A<sub>2</sub> -induced human prostate smooth muscle contraction by the integrin α2β1 inhibitor BTT-3033 and the integrin-linked kinase inhibitor Cpd22Bingsheng Li, Xiaolong Wang, Ruixiao Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 2010
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosisMartin Hennenberg, Jonel Trebicka, Zaki Kohistani, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
British Journal of Pharmacology|March 26, 2018
Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3Qingfeng Yu, Christian Gratzke, Yiming Wang, et al.
European Journal of Pharmacology|February 5, 2020
Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α<sub>1</sub>-blockersXiaolong Wang, Bingsheng Li, Anna Ciotkowska, et al.
British Journal of Pharmacology|September 18, 2016
Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2Yiming Wang, Christian Gratzke, Alexander Tamalunas, et al.
Frontiers in Pharmacology|May 15, 2023
Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003Yuhan Liu, Ruixiao Wang, Ru Huang, et al.
Journal of Hepatology|July 17, 2010
Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cellsJonel Trebicka, Martin Hennenberg, Margarete Odenthal, et al.
Frontiers in Pharmacology|April 23, 2020
Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766Bingsheng Li, Qingfeng Yu, Ruixiao Wang, et al.
The Prostate|February 28, 2019
New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic interventionQingfeng Yu, Christian Gratzke, Yiming Wang, et al.
European Journal of Pharmacology|March 19, 2017
Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow regionMartin Hennenberg, Alexander Tamalunas, Yiming Wang, et al.
The Prostate|May 26, 2020
Inhibition of neurogenic and thromboxane A<sub>2</sub> -induced human prostate smooth muscle contraction by the integrin α2β1 inhibitor BTT-3033 and the integrin-linked kinase inhibitor Cpd22Bingsheng Li, Xiaolong Wang, Ruixiao Wang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 6, 2010
Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosisMartin Hennenberg, Jonel Trebicka, Zaki Kohistani, et al.
Pageof 11